抗双链DNA在系统性红斑狼疮中的预后价值。
Prognostic value of anti-dsDNA in SLE.
作者信息
Swaak A J, Groenwold J, Aarden L A, Statius van Eps L W, Feltkamp E W
出版信息
Ann Rheum Dis. 1982 Aug;41(4):388-95. doi: 10.1136/ard.41.4.388.
Abstract
In a prospective longitudinal study 130 patients with systemic lupus erythematosus (SLE) were studied at least monthly for a relationship between the anti-dsDNA levels and disease activity. We observed 13 patients who developed 15 periods of exacerbations of their disease. All 15 exacerbations were preceded by a continuous increase of the anti-dsDNA levels. In 13 of the 15 exacerbations studied the exacerbation was preceded by an increase of anti-dsDNA with a doubling time (T2) of less than 6 weeks; in 4 of the 5 other exacerbations the T2 was less than 10 weeks. Four other patients with an increase of the anti-dsDNA levels showed no exacerbation. In these 4 patients the T2 was larger than 10 weeks. The other 113 patients did not show an increase of anti-dsDNA over the 2 years of monitoring and showed no signs of serious disease activity (no major symptoms). These observations suggest that an SLE patient who is followed up frequently and who shows a continuous increase of anti-dsDNA witha T2 shorter than 10 weeks is bound to develop an exacerbation.
摘要
在一项前瞻性纵向研究中，对130例系统性红斑狼疮（SLE）患者进行了至少每月一次的随访，以研究抗双链DNA（anti-dsDNA）水平与疾病活动度之间的关系。我们观察到13例患者出现了15次疾病加重期。所有15次加重期之前均有anti-dsDNA水平持续升高。在研究的15次加重期中，有13次加重期之前anti-dsDNA水平升高，其倍增时间（T2）小于6周；在其他5次加重期中，有4次T2小于10周。另外4例anti-dsDNA水平升高的患者未出现疾病加重。这4例患者的T2大于10周。在2年的监测期内，其他113例患者的anti-dsDNA水平未升高，也未出现严重疾病活动的迹象（无主要症状）。这些观察结果表明，频繁随访且anti-dsDNA持续升高、T2短于10周的SLE患者必然会出现疾病加重。
相似文献
1
Prognostic value of anti-dsDNA in SLE.抗双链DNA在系统性红斑狼疮中的预后价值。
Ann Rheum Dis. 1982 Aug;41(4):388-95. doi: 10.1136/ard.41.4.388.
2
Measurement of increases in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in systemic lupus erythematosus. A long-term, prospective study.测量抗双链DNA抗体水平升高作为系统性红斑狼疮疾病加重的预测指标。一项长期前瞻性研究。
Arthritis Rheum. 1990 May;33(5):634-43. doi: 10.1002/art.1780330505.
3
Azathioprine in the treatment of systemic lupus erythematosus. A three-year prospective study.硫唑嘌呤治疗系统性红斑狼疮。一项为期三年的前瞻性研究。
Clin Rheumatol. 1984 Sep;3(3):285-91. doi: 10.1007/BF02032333.
4
Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus.补体谱和抗双链DNA在系统性红斑狼疮中的预测价值。
Ann Rheum Dis. 1986 May;45(5):359-66. doi: 10.1136/ard.45.5.359.
5
Changes in plasma levels of interleukin-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in systemic lupus erythematosus.系统性红斑狼疮中白细胞介素-2受体血浆水平变化与疾病加重及抗双链DNA和补体水平的关系
Clin Exp Immunol. 1990 Oct;82(1):21-6. doi: 10.1111/j.1365-2249.1990.tb05398.x.
6
Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA).将抗双链DNA作为诊断工具的检测：对441例非系统性红斑狼疮抗双链DNA抗体（抗dsDNA）患者的前瞻性研究。
Ann Rheum Dis. 1985 Apr;44(4):245-51. doi: 10.1136/ard.44.4.245.
7
Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus.抗双链DNA和补体谱作为系统性红斑狼疮的预后指导
Arthritis Rheum. 1979 Mar;22(3):226-35. doi: 10.1002/art.1780220304.
8
9
Changes in Farr radioimmunoassay and EliA fluorescence immunoassay anti-dsDNA in relation to exacerbation of SLE.Farr 放射免疫分析和 EliA 荧光免疫分析抗双链 DNA 在 SLE 加重中的变化。
Lupus. 2013 Oct;22(11):1169-73. doi: 10.1177/0961203313500368. Epub 2013 Aug 8.
10
Clinical significance of antibodies to double stranded DNA (dsDNA) for systemic lupus erythematosus (SLE).抗双链DNA（dsDNA）抗体对系统性红斑狼疮（SLE）的临床意义。
Clin Rheumatol. 1987 Jun;6 Suppl 1:56-73. doi: 10.1007/BF02200721.
引用本文的文献
1
Identification EXOSC4 as a novel autoantigen of interstitial lung disease in rheumatoid arthritis.鉴定EXOSC4作为类风湿关节炎间质性肺疾病的一种新型自身抗原。
J Transl Med. 2025 Jul 10;23(1):765. doi: 10.1186/s12967-025-06667-0.
2
Targeting Bruton's tyrosine kinase (BTK) as a signaling pathway in immune-mediated diseases: from molecular mechanisms to leading treatments.靶向布鲁顿酪氨酸激酶（BTK）作为免疫介导性疾病的信号通路：从分子机制到主要治疗方法。
Adv Rheumatol. 2024 Aug 21;64(1):61. doi: 10.1186/s42358-024-00401-y.
3
SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus-an analysis of anti-double-stranded DNA monitoring.SMART-SLE：系统性红斑狼疮的血清学监测和重复检测——抗双链 DNA 监测分析。
Rheumatology (Oxford). 2024 Feb 1;63(2):525-533. doi: 10.1093/rheumatology/kead231.
4
The emerging role of noncoding RNAs in systemic lupus erythematosus: new insights into the master regulators of disease pathogenesis.非编码RNA在系统性红斑狼疮中的新兴作用：对疾病发病机制主要调节因子的新见解
Ther Adv Chronic Dis. 2023 Apr 3;14:20406223231153572. doi: 10.1177/20406223231153572. eCollection 2023.
5
The BILAG2004-Pregnancy Index is a valid disease activity outcome measure for pregnant SLE patients.BILAG2004妊娠指数是评估妊娠系统性红斑狼疮患者疾病活动度的有效指标。
Rheumatol Adv Pract. 2022 Oct 3;6(3):rkac081. doi: 10.1093/rap/rkac081. eCollection 2022.
6
Treatments and outcomes in Chinese patients with serologically active clinically quiescent systemic lupus erythematosus: a retrospective observational study.血清学活动但临床无活动的系统性红斑狼疮中国患者的治疗和结局：一项回顾性观察研究。
Arthritis Res Ther. 2021 Oct 29;23(1):275. doi: 10.1186/s13075-021-02641-5.
7
Bruton's Tyrosine Kinase Inhibitors: A New Therapeutic Target for the Treatment of SLE?布鲁顿酪氨酸激酶抑制剂：系统性红斑狼疮治疗的新靶点？
Immunotargets Ther. 2020 Jun 2;9:105-110. doi: 10.2147/ITT.S240874. eCollection 2020.
8
Utility of the AVISE Connective Tissue Disease test in predicting lupus diagnosis and progression.AVISE 连接组织疾病检测在预测狼疮诊断和进展中的效用。
Lupus Sci Med. 2020 Mar 18;7(1):e000345. doi: 10.1136/lupus-2019-000345. eCollection 2020.
9
An Update on Antibodies to Necleosome Components as Biomarkers of Sistemic Lupus Erythematosus and of Lupus Flares.核小体成分自身抗体作为系统性红斑狼疮及狼疮活动的生物标志物的研究进展
Int J Mol Sci. 2019 Nov 18;20(22):5799. doi: 10.3390/ijms20225799.
10
Dendritic cell-associated B7-H3 suppresses the production of autoantibodies and renal inflammation in a mouse model of systemic lupus erythematosus.树突状细胞相关的 B7-H3 抑制系统性红斑狼疮小鼠模型中自身抗体的产生和肾脏炎症。
Cell Death Dis. 2019 May 21;10(6):393. doi: 10.1038/s41419-019-1623-0.
本文引用的文献
1
The use of polyethylene glycol precipitation to detect low-avidity anti-DNA antibodies in systemic lupus erythematosus.利用聚乙二醇沉淀法检测系统性红斑狼疮中低亲和力抗DNA抗体。
J Immunol Methods. 1980;39(1-2):165-80. doi: 10.1016/0022-1759(80)90305-1.
2
Measurement of serum DNA-binding activity in systemic lupus erythematosus.系统性红斑狼疮患者血清DNA结合活性的测定
N Engl J Med. 1969 Sep 25;281(13):701-5. doi: 10.1056/NEJM196909252811304.
3
Properties of bacteriophage PM2: a lipid-containing bacterial virus.噬菌体PM2的特性：一种含脂质的细菌病毒。
Virology. 1968 Apr;34(4):738-47. doi: 10.1016/0042-6822(68)90094-9.
4
Immunologic factors and clinical activity in systemic lupus erythematosus.系统性红斑狼疮中的免疫因素与临床活动
N Engl J Med. 1968 Mar 7;278(10):533-8. doi: 10.1056/NEJM196803072781004.
5
Native DNA binding in rheumatoid arthritis.类风湿关节炎中的天然DNA结合
Ann Rheum Dis. 1974 Jul;33(4):357-60. doi: 10.1136/ard.33.4.357.
6
Antibodies to native DNA in discoid lupus erythematosus.盘状红斑狼疮中针对天然DNA的抗体。
Br J Dermatol. 1974 Aug;91(2):175-81. doi: 10.1111/j.1365-2133.1974.tb15863.x.
7
Serum DNA binding activity in healthy subjects and in rheumatic disease.健康受试者和风湿性疾病患者的血清DNA结合活性。
Arthritis Rheum. 1974 Jan-Feb;17(1):63-71. doi: 10.1002/art.1780170110.
8
Frequency of anti-DNA antibodies in SLE. RA and other diseases. Experience wiht the ammonium sulphate precipitation technique.系统性红斑狼疮、类风湿关节炎及其他疾病中抗DNA抗体的频率。硫酸铵沉淀技术的经验
Scand J Rheumatol Suppl. 1975;11:42-51. doi: 10.3109/03009747509095628.
9
Immunology of DNA. II. The effect of size and structure of the antigen on the Farr assay.DNA的免疫学。II. 抗原的大小和结构对法尔测定的影响。
J Immunol Methods. 1976;10(1):39-48. doi: 10.1016/0022-1759(76)90005-3.
10
Immunology of DNA. IV. Quantitative aspects of the Farr assay.DNA的免疫学。IV. 法尔氏测定法的定量方面。
J Immunol Methods. 1976;11(2):153-63. doi: 10.1016/0022-1759(76)90143-5.
Zotero 插件